跳至主要内容
临床试验/NCT05913713
NCT05913713已完成不适用

High Intensity Interval Training: Optimizing Exercise Therapy to Mitigate Cardiovascular Disease Risk Following Breast Cancer Chemotherapy

University of Florida1 个研究点 分布在 1 个国家目标入组 37 人开始时间: 2024年3月7日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
37
试验地点
1
主要终点
Percent completed vs. planned exercise duration

研究概览

简要总结

Chemotherapy is an effective breast cancer treatment, which helped to increase the 5-year survival rate to approximately 95%. However, breast cancer survivors have a higher risk of cardiovascular disease (CVD) due to chemotherapy than adults without cancer. Cardiovascular rehabilitation can be an effective strategy to decrease the incidence of CVD and its risk factors in this population. The proposed study may help to examine the effect and durability of a novel high-intensity interval training compared to moderate-intensity continuous training on cardiovascular rehabilitation in breast cancer survivors.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •female patients based on biological sex
  • •18 to 85 years of age
  • •diagnosis of primary, invasive, non-metastatic, stages I-III breast cancer
  • •completed chemotherapy for breast cancer (anthracycline, alkylating agent and/or taxane) more than 6 months but less than 18 months prior to study enrollment. Adjuvant endocrine therapy for breast cancer (e.g., ovarian suppression, SERMs, SERDs, AIs), CDK4/6 inhibitors, PARP inhibitors, HER2 targeted agents, immunotherapy, and bisphosphonates are allowed within 6 months of study enrollment and during study participation
  • •absence of contraindications to exercise or to participate in study
  • •study clinician approval

排除标准

  • •do not meet inclusion criteria
  • •scheduled to receive surgery or radiation therapy during the intervention period
  • •any relevant cardiovascular diseases (stroke, heart failure, myocardial ischemia during maximal graded exercise test, myocardial infarction, angina pectoris, coronary artery bypass surgery or angioplasty or coronary stent)
  • •lymphedema stage ≥2 prior to study enrollment
  • •are pregnant
  • •current participation in other experimental interventions that may confound interpretation of study findings (e.g., dietary intervention for weight loss)

研究组 & 干预措施

Usual Care (UC)

Other

Research participants will continue their habitual physical activity for the duration of the study. Once they complete the study, they will have the opportunity to perform supervised HIIT or MICT at home for 3 days/week for 12 weeks (research participants can choose either type of exercise).

干预措施: 12-week Intervention Period (Behavioral)

Usual Care (UC)

Other

Research participants will continue their habitual physical activity for the duration of the study. Once they complete the study, they will have the opportunity to perform supervised HIIT or MICT at home for 3 days/week for 12 weeks (research participants can choose either type of exercise).

干预措施: 12-week Observation Period (Behavioral)

High Intensity Interval Training (HIIT)

Experimental

Supervised home-based high-intensity interval training will be performed on an all-extremity stationary cycle 3 days/week for 12 weeks.

干预措施: 12-week Intervention Period (Behavioral)

High Intensity Interval Training (HIIT)

Experimental

Supervised home-based high-intensity interval training will be performed on an all-extremity stationary cycle 3 days/week for 12 weeks.

干预措施: 12-week Observation Period (Behavioral)

Moderate Intensity Continuous Training (MICT)

Experimental

Supervised home-based moderate-intensity continuous training will be performed on an all-extremity stationary cycle 3 days/week for 12 weeks.

干预措施: 12-week Intervention Period (Behavioral)

Moderate Intensity Continuous Training (MICT)

Experimental

Supervised home-based moderate-intensity continuous training will be performed on an all-extremity stationary cycle 3 days/week for 12 weeks.

干预措施: 12-week Observation Period (Behavioral)

结局指标

主要结局

Percent completed vs. planned exercise duration

时间窗: Throughout the 12 weeks of supervised home-based exercise training

The investigators will collect information throughout the exercise intervention regarding % completed vs. planned exercise min/session.

Change in brachial FMD

时间窗: Baseline, Following a 12-week intervention period, Following a 12-week observation period

Flow-mediated dilation (FMD) is an established non-invasive measure of endothelial function. Brachial artery FMD will be determined via ultrasonography in response to reactive hyperemia following 5-min forearm ischemia.

Change in cardiac function (global longitudinal strain)

时间窗: Baseline, Following a 12-week intervention period, Following a 12-week observation period

Global longitudinal strain is a marker of acute subclinical cardiotoxicity and is recommended for monitoring cancer patients at risk of cancer therapy-related cardiac dysfunction.

Percent completed vs. planned exercise frequency

时间窗: Throughout the 12 weeks of supervised home-based exercise training

The investigators will collect information throughout the exercise intervention regarding % completed vs. planned exercise sessions/week.

Percent completed vs. planned exercise intensity

时间窗: Throughout the 12 weeks of supervised home-based exercise training

The investigators will collect information throughout the exercise intervention regarding % completed vs. planned exercise intensity/session.

Number of participants who experience adverse events as defined by most recent CTCAE throughout the exercise intervention

时间窗: Throughout the 12 weeks of supervised home-based exercise training

To evaluate safety plans are in place for determination and monitoring of adverse events according to the most recent National Cancer Institute Common Terminology Criteria for Adverse Events. Classification for seriousness, expectedness, severity and relationship to study intervention will be based on the NIH provided definitions.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验